Alkermes Plc
NASDAQ:ALKS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Alkermes Plc
NASDAQ:ALKS
|
IE |
|
Alexium International Group Ltd
ASX:AJX
|
AU |
|
Eliem Therapeutics Inc
NASDAQ:ELYM
|
US |
|
D
|
Deluxe Corp
XMUN:DL8
|
US |
|
M
|
Mast Energy Developments PLC
F:97D
|
UK |
|
N
|
Nissan Chemical Corp
XMUN:NSC
|
JP |
|
Advanced Container Technologies Inc
OTC:ACTX
|
US |
|
D
|
Duni AB
F:2DU
|
SE |
|
P
|
Polyplex Thailand PCL
SET:PTL
|
TH |
|
B
|
Boot Barn Holdings Inc
F:OBB
|
US |
|
KBC Groep NV
OTC:KBCSF
|
BE |
|
N
|
Netlist Inc
OTC:NLST
|
US |
|
Technip Energies NV
F:68F
|
FR |
|
W
|
WPP PLC
F:0WP
|
UK |
Bankruptcy Probability
Alkermes Plc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Alkermes Plc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IE |
|
Alkermes Plc
NASDAQ:ALKS
|
7.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
439.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
212.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
182B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Alkermes Plc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Alkermes Plc has total debt of 1.5B USD. This includes both short-term (0 USD) and long-term (1.5B USD) debt.
You can find a full breakdown on its Balance Sheet.
